Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
18 authors.
Athanasia Athanasaki2nd Department of Neurology, School of Medicine, National and Kapodistrian University of Athens, "Attikon" General University Hospital, 12462 Athens, Greece.ORCID 0009-0006-2823-2825
Ioanna Tsantzali2nd Department of Neurology, School of Medicine, National and Kapodistrian University of Athens, "Attikon" General University Hospital, 12462 Athens, Greece.ORCID 0000-0002-7582-7059
Christos KroupisDepartment of Clinical Biochemistry, School of Medicine, National and Kapodistrian University of Athens, "Attikon" General University Hospital, 12462 Athens, Greece.ORCID 0000-0002-5876-2599
Aikaterini Theodorou2nd Department of Neurology, School of Medicine, National and Kapodistrian University of Athens, "Attikon" General University Hospital, 12462 Athens, Greece.ORCID 0000-0001-7229-2610
Fotini Boufidou1st Department of Neurology, School of Medicine, National and Kapodistrian University of Athens, Neurochemistry and Biological Markers Unit, "Eginition" Hospital, 11528 Athens, Greece.ORCID 0000-0001-9691-9465
Vasilios C Constantinides1st Department of Neurology, School of Medicine, National and Kapodistrian University of Athens, Neurochemistry and Biological Markers Unit, "Eginition" Hospital, 11528 Athens, Greece.ORCID 0000-0001-7432-5009
John S Tzartos2nd Department of Neurology, School of Medicine, National and Kapodistrian University of Athens, "Attikon" General University Hospital, 12462 Athens, Greece.
Georgios Velonakis2nd Department of Radiology, National and Kapodistrian University of Athens, Research Unit of Radiology, "Attikon" General University Hospital, 12462 Athens, Greece.ORCID 0000-0002-0050-284X
Christina Zompola2nd Department of Neurology, School of Medicine, National and Kapodistrian University of Athens, "Attikon" General University Hospital, 12462 Athens, Greece.
Amalia Michalopoulou2nd Department of Neurology, School of Medicine, National and Kapodistrian University of Athens, "Attikon" General University Hospital, 12462 Athens, Greece.
Panagiotis G Paraskevas2nd Department of Neurology, School of Medicine, National and Kapodistrian University of Athens, "Attikon" General University Hospital, 12462 Athens, Greece.
Anastasios Bonakis2nd Department of Neurology, School of Medicine, National and Kapodistrian University of Athens, "Attikon" General University Hospital, 12462 Athens, Greece.
Sotirios Giannopoulos2nd Department of Neurology, School of Medicine, National and Kapodistrian University of Athens, "Attikon" General University Hospital, 12462 Athens, Greece.ORCID 0000-0001-7443-5179
Paraskevi MoutsatsouDepartment of Clinical Biochemistry, School of Medicine, National and Kapodistrian University of Athens, "Attikon" General University Hospital, 12462 Athens, Greece.ORCID 0000-0001-9549-2295
Georgios Tsivgoulis2nd Department of Neurology, School of Medicine, National and Kapodistrian University of Athens, "Attikon" General University Hospital, 12462 Athens, Greece.ORCID 0000-0002-0640-3797
Elisabeth Kapaki1st Department of Neurology, School of Medicine, National and Kapodistrian University of Athens, Neurochemistry and Biological Markers Unit, "Eginition" Hospital, 11528 Athens, Greece.
George P Paraskevas2nd Department of Neurology, School of Medicine, National and Kapodistrian University of Athens, "Attikon" General University Hospital, 12462 Athens, Greece.ORCID 0000-0002-2481-3060
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
Alzheimer's disease (AD) is the most common cause of cognitive decline. Among the various susceptibility genes, the gene of apolipoprotein E (
Indexed as
Alzheimer DiseaseApolipoproteins ECognition DisordersCognitive DysfunctionAgedAged, 80 and overAllelesApolipoprotein E4BiomarkersFemaleGenetic Predisposition to DiseaseGenotypeGreeceHeterozygoteHumansMaleApoE protein, humanApolipoprotein E4Apolipoproteins EBiomarkersAlzheimer’s diseaseamyloid betaapolipoprotein Ecognitive impairmentdementiaphospho-tau proteintau protein
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.